trial · primary record
Teriflunomide
HAM/TSP
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2029-12-31 |
| Primary endpoint | ex vivo spontaneous lymphoproliferation in HAM/TSP patients receiving teriflunomide |
| Registry ID | NCT04799288 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:13.022Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04799288
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.